Suchergebnisse - "Rodriguez-Vida, Alejo"

PubPharm (89)

1

Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration : Results from the PROOF302 Phase 3 Trial

enthalten in: European urology | 2024

von Pal, S. | Grivas, P. | Gupta, S. | +19

2

Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103)

enthalten in: Journal of clinical pharmacology | 2024

von Garralda, E. | Oh, D. | Italiano, A. | +16

3

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

enthalten in: The New England journal of medicine | 2024

von Powles, T. | Valderrama, B. | Gupta, S. | +122

4

Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

enthalten in: European urology oncology | 2024

von Jiménez, N. | Garcia de Herreros, M. | Reig, �. | +23

5

Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors

enthalten in: Clinical and translational science | 2024

von Robbrecht, D. | Grob, J. | Bechter, O. | +20

6

Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)

enthalten in: British journal of cancer | 2024

von Font, A. | Mellado, B. | Climent, M. | +18

7

Biomarker and pharmacodynamic activity of the transforming growth factor‐beta ( TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors

enthalten in: Clinical and Translational Science | 2024

von Robbrecht, D. | Grob, J. | Bechter, O. | +20

8

Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103)

enthalten in: The Journal of Clinical Pharmacology | 2024

von Garralda, E. | Oh, D. | Italiano, A. | +16

9

Publisher Correction : Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

enthalten in: Nature medicine | 2023

von Powles, T. | Kockx, M. | Rodriguez-Vida, A. | +22

ErratumFor: Nat Med. 2019 Nov;25(11):1706-1714. - PMID 31686036

10

Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2023

von Climent, M. | Álvarez, C. | Morales, R. | +15

1
2
3
4
5
6
7
8
9
Nächster »
[9]